Embla Medical hf.
OSSFF
$4.15
-$0.15-3.49%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.64% | 23.68% | 71.98% | -33.21% | -16.73% |
| Total Depreciation and Amortization | -12.43% | 6.83% | 17.66% | 57.43% | -42.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -76.41% | -- |
| Total Other Non-Cash Items | -3,028.29% | -87.07% | 267.50% | -85.66% | 3,506.87% |
| Change in Net Operating Assets | 372.25% | 125.67% | -20.91% | -384.66% | -21.73% |
| Cash from Operations | 9.02% | 108.22% | 60.73% | -67.08% | 0.86% |
| Capital Expenditure | 25.73% | 22.91% | -177.15% | -188.00% | 147.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -118.50% | -221.08% | 68.51% | -139.10% | 833.10% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -127.72% | -123.24% | 182.35% | 38.70% | -9,885.71% |
| Cash from Investing | -24.92% | -63.78% | 36.75% | -343.18% | 147.59% |
| Total Debt Issued | -- | -- | 563.40% | 140.16% | -- |
| Total Debt Repaid | -79.98% | 74.01% | -973.99% | -2.01% | 78.69% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -4.91% | 11.12% | -135.24% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.98% | -515,700.00% | -- | -- | -- |
| Cash from Financing | -36.34% | -76.79% | -1,609.70% | 102.57% | -26.73% |
| Foreign Exchange rate Adjustments | 207.29% | -116.04% | -13.33% | 159.83% | -290.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -94.56% | 239.22% | -58.16% | 13.14% | 24.12% |